SEC Form 4 · accession 0001562180-18-004304
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John L Higgins
Director
Period of report
Oct 25, 2018
Accepted (ET)
Oct 29, 2018 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 25, 2018 | A | 514 | $0.00 | A | 3,526 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F1 | $179.84 | Oct 25, 2018 | A | 1,898 | A | — | Oct 25, 2028 | Common Stock | 1,898 | 1,898 | D |
| Stock Option (right to buy) | $91.78 | holding | — | — | — | Oct 30, 2014 | Oct 30, 2024 | Common Stock | 4,000 | 4,000 | D |
| Stock Option (right to buy) | $87.39 | holding | — | — | — | Oct 31, 2013 | Oct 30, 2023 | Common Stock | 4,000 | 4,000 | D |
| Stock Option (right to buy) | $87.34 | holding | — | — | — | Oct 29, 2016 | Oct 28, 2025 | Common Stock | 4,260 | 4,260 | D |
| Stock Option (right to buy) | $70.35 | holding | — | — | — | Oct 27, 2011 | Oct 26, 2021 | Common Stock | 5,000 | 5,000 | D |
| Stock Option (right to buy) | $66.90 | holding | — | — | — | Oct 25, 2012 | Oct 24, 2022 | CommonS tock | 5,000 | 5,000 | D |
| Stock Option (right to buy) | $63.03 | holding | — | — | — | Oct 29, 2009 | Oct 28, 2019 | Common Stock | 5,000 | 5,000 | D |
| Stock Option (right to buy) | $61.46 | holding | — | — | — | Oct 28, 2010 | Oct 27, 2020 | Common Stock | 5,000 | 5,000 | D |
| Stock Option (right to buy) | $61.08 | holding | — | — | — | May 19, 2010 | May 18, 2019 | Common Stock | 10,000 | 10,000 | D |
| Stock Options (Right to buy) | $125.05 | holding | — | — | — | Oct 25, 2018 | Oct 26, 2027 | Common Stock | 3,125 | 3,125 | D |
| Stock Options (Right to buy) | $101.19 | holding | — | — | — | Oct 26, 2017 | Oct 26, 2026 | Common Stock | 3,985 | 3,985 | D |
Explanation of responses
- F1This option vests on the earlier of the one year anniversary of the grant date (10/25/2019) or the date of Bio-Techne 2019 Annual Meeting of Shareholders.